Skip to main content
Clinical Trials/NCT03421717
NCT03421717CompletedNot Applicable

The Effect of Peri-implant Surgery and Chair-side Supportive Post Surgical Peri-implant Therapy

University of Oslo0 sites46 target enrollmentStarted: November 1, 2012Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
46
Primary Endpoint
Inflammation control

Study Overview

Brief Summary

Peri-implantitis is defined as inflammation in the mucosa surrounding an oral implant with loss of supporting bone. The goals of peri-implantitis treatment are to resolve inflammation and to arrest the progression of disease. It is important to systematically gather information on the effect of surgical peri-implant treatment and to assess different protocols regarding chair-side maintenance of peri-implant tissue after surgery

The aims of this clinical investigation are to evaluate the clinical, microbiological and radiographic outcomes of surgical treatment of peri-implantitis and to evaluate the efficacy of 2 supportive treatment protocols based on the use of titanium cyrettes or by the use of a flexible, biodegradable chitosan brush. Furthermore, to evaluate the impact of this therapy on selected biochemical markers associated with chronic inflammation and bone tissue destruction.

Detailed Description

Little is known about the effect of chair-side maintenance of dental implants after peri-implantitits surgery. Traditionally, the maintenance has been performed by titanium curettes to remove microbiological deposits from the submucosal area.

The Labrida biodegradable brush is a novel debridement device intended for use on dental implants. The concept of using a biodegradable material is related to the suggested problems with leaving remnants on the treated implant surface which would be negative from a bone regenerative aspect. The use of a flexible brush relates to the access problems when treating dental implants both related to the threads as well as due to the prosthetic supra construction hindering access for debridement with regular instruments developed for teeth. The material used in the brush will be Chitosan which is a natural polysaccharide, chitosan (poly-N-acetyl glucosaminoglycan), which is a nontoxic and bioabsorbable (REK-approval 2012/791 polymer).

H0: It is possible to maintain peri-implant health after surgical peri-implantitis treatment. There is no short- or long term clinical or radiographical differences between patients surgically treated for peri-implantitis maintained by the use of titanium cyrettes or with the Labrida brush in chair-side supportive care

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Investigator, Outcomes Assessor)

Masking Description

Maintenance treatment (test/control) was performed after the investigator left the room. Investigator did not have access to the registration forms where information regarding assignment (test/control) was noted

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Overt peri-implantitis presenting at least one implant with;
  • •radiographic bone loss ≥ 2.0 mm
  • •bleeding on probing (BoP)

Exclusion Criteria

  • •radiotherapy
  • •chemotherapy
  • •systemic long-term corticosteroid treatment
  • •pregnancy or nursing
  • •anatomical abnormalities
  • •history of previous treatment of peri-implantitis within 6 months after the screening
  • •American Society of Anesthesiologists (ASA) classification for assessing the fitness of patients before surgery > 2

Arms & Interventions

Test

Experimental

Treatment/maintenance of implants postsurgically performed by the use of chitosan brushes

Intervention: Chitosan brush (Device)

Control

Active Comparator

Treatment/maintenance of implants postsurgically performed by the use of titanium curettes

Intervention: Chitosan brush (Device)

Outcomes

Primary Outcomes

Inflammation control

Time Frame: 3 months

Absence/presence of bleeding on probing and deep peri-implant pockets

Secondary Outcomes

  • Progressive bone loss(3 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Odd Carsten Koldsland

Associate professor

University of Oslo

Similar Trials